throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.
`
`Petitioner
`
`v.
`
`YEDA RESEARCH AND DEVELOPMENT CO. LTD.
`
`Patent Owner
`
`Case No. IPR2015-00644
`
`Patent No. 8,399,413
`
`PATENT OWNER’S MOTION FOR PRO HAC VICE ADMISSION OF
`DARYL L. WIESEN UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Case No. IPR2015-00644
`
`I.
`
`STATEMENT OF THE PRECISE RELIEF REQUESTED
`
`Pursuant to the Board’s “Notice of Filing Date Accorded to Petition and
`
`Time for Filing Patent Owner Preliminary Response,” dated February 25, 2015
`
`(Paper No. 5), authorizing the parties to file motions for pro hac vice admission
`
`under 37 C.F.R. § 42.10(c), Patent Owner Yeda Research and Development Co.
`
`Ltd. respectfully requests that the Board allow Daryl L. Wiesen to appear pro hac
`
`vice on its behalf in this proceeding. Petitioner has stated that it will not oppose
`
`this motion.
`
`II. REASONS THE REQUESTED RELIEF SHOULD BE GRANTED
`As set forth in the Statement of Material Facts below, and as required by 37
`
`C.F.R. § 42.10(c), Patent Owner has demonstrated good cause to admit Mr.
`
`Wiesen pro hac vice in this proceeding. In particular, Patent Owner’s lead counsel
`
`is a registered practitioner, and Mr. Wiesen is an experienced litigating attorney
`
`having an established familiarity with the subject matter at issue in this proceeding.
`
`Furthermore, this motion is being filed more than twenty one days after
`
`service of the petition; includes a statement of facts showing good cause for the
`
`Board to recognize Mr. Wiesen pro hac vice; and is being filed concurrently with
`
`Exhibit 2137, the Declaration of Daryl L. Wiesen in Support of Patent Owner’s
`
`Motion for Pro Hac Vice Admission of Daryl L. Wiesen (“Wiesen Decl.”), all in
`
`accordance with the “Order Authorizing Motion for Pro Hac Vice Admission” in
`
`
`
`
`1
`
`

`
`Case No. IPR2015-00644
`
`Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper 7 at 3 (P.T.A.B.
`
`Oct. 15, 2013).
`
`III. STATEMENT OF MATERIAL FACTS
`1. 37 C.F.R. § 42.10(c) provides that “[t]he Board may recognize counsel pro
`
`hac vice during a proceeding upon a showing of good cause, subject to the
`
`condition that lead counsel be a registered practitioner and to any other
`
`conditions as the Board may impose. For example, where the lead counsel is a
`
`registered practitioner, a motion to appear pro hac vice by counsel who is not a
`
`registered practitioner may be granted upon showing that counsel is an
`
`experienced litigating attorney and has an established familiarity with the subject
`
`matter at issue in the proceeding.”
`
`2. Elizabeth J. Holland, lead counsel for Patent Owner Yeda Research and
`
`Development Co. Ltd. in this proceeding, is a registered practitioner holding
`
`Registration No. 47,657.
`
`3. As set forth in the Wiesen Decl., Mr. Wiesen is an experienced litigating
`
`attorney. Specifically, Mr. Wiesen has nearly 20 years of experience
`
`representing clients in patent litigations, primarily in the chemical arts, in United
`
`States district courts and the Court of Appeals for the Federal Circuit. (Wiesen
`
`Decl., ¶¶ 2-3). Mr. Wiesen also has over a decade of experience litigating cases
`
`
`
`
`2
`
`

`
`Case No. IPR2015-00644
`
`on behalf of the Patent Owner and Teva entities, both generally and in litigations
`
`related to GA and Copolymer 1. (Wiesen Decl., ¶¶ 5-7).
`
`4. Mr. Wiesen also has an established familiarity with the precise subject
`
`matter at issue in this proceeding. Petitioner and Patent Owner are currently
`
`involved in district court litigation involving U.S. Patent No. 8,399,413 (“the
`
`’413 patent”), the patent at issue in this proceeding, against Petitioner and several
`
`other defendants in Teva Pharmaceuticals USA, Inc. et al. v. Mylan
`
`Pharmaceuticals Inc. et al., Civil Action No. 1:14-cv-01278-GMS (D.Del.)
`
`(consolidated as In re Copaxone 40 MG Consolidated Cases, Case No. 1:14-cv-
`
`01171-GMS (D. Del.)), as well as in Teva Pharmaceuticals USA, Inc. et al. v.
`
`Mylan Pharmaceuticals Inc. et al., Case No. 1:14-cv-00167-IMK (N.D.W.Va).
`
`Mr. Wiesen is litigation counsel for Teva Pharmaceuticals USA, Inc., Teva
`
`Pharmaceutical Industries Ltd., Teva Neuroscience, Inc. and Yeda Research and
`
`Development Co., Ltd., in these litigations. In the course of this representation,
`
`he has developed a strong familiarity with the ’413 patent, its prosecution history,
`
`the general subject matter to which the ’413 patent is directed, and the prior art
`
`references relied upon by Petitioner in support of its invalidity grounds in this
`
`proceeding. (Wiesen Decl., ¶ 8). Additionally, Mr. Wiesen has thoroughly
`
`reviewed the Petition and accompanying Exhibits submitted in this proceeding.
`
`(Id.).
`
`
`
`
`3
`
`

`
`Case No. IPR2015-00644
`
`5. Mr. Wiesen has attested to the each of the requirements set forth in
`
`paragraph 2(b)(i)-(viii) of the “Order Authorizing Motion for Pro Hac Vice
`
`Admission” in Case IPR2013-00639, Paper 7 at 3. (Wiesen Decl., ¶¶ 3, 4, 6-8, 9-
`
`13).
`
`IV. CONCLUSION
`In view of the foregoing, Patent Owner respectfully submits that the
`
`requirements of 37 C.F.R. § 42.10(c) have been satisfied, and requests an Order
`
`permitting Daryl L. Wiesen to appear pro hac vice on its behalf in this proceeding.
`
`
`
`Dated: December 18, 2015
`
`Respectfully submitted,
`
`
`
`/Elizabeth J. Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Goodwin Procter LLP
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`Tel: 212-813-8800
`Fax: 212-355-3333
`
`Counsel for Patent Owner Yeda Research
`and Development Co. Ltd.
`
`
`
`
`4
`
`

`
`
`
`CERTIFICATION OF SERVICE
`
`The undersigned hereby certifies that “PATENT OWNER’S MOTION FOR
`
`PRO HAC VICE ADMISSION OF DARYL L. WIESEN UNDER 37 C.F.R. §
`
`42.10(c),” and “EXHIBIT 2137- DECLARATION OF DARYL L. WIESEN IN
`
`SUPPORT OF PATENT OWNER’S MOTION FOR PRO HAC VICE
`
`ADMISSION OF DARYL L. WIESEN UNDER 37 C.F.R. § 42.10(c)” were
`
`served electronically via e-mail on December 18, 2015 on the following:
`
`Jeffrey W. Guise
`
`jguise@wsgr.com
`
`Brandon M. White
`
`BMWhite@perkinscoie.com
`
`Shannon Bloodworth
`
`sbloodworth@perkinscoie.com
`
`David Anstaett
`
`DAnstaett@perkinscoie.com
`
`Richard Torczon
`
`rtorczon@wsgr.com
`
`
`
`Dated: December 18, 2015
`
`/Eleanor M. Yost/
`
`
`
`
`
`Eleanor M. Yost

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket